These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10436426)
21. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis. Liu Q; Zhang GW; Zhu CY; Wei JX; Tian X; Li Y; Li XD Cancer Biomark; 2016; 16(2):281-9. PubMed ID: 26756619 [TBL] [Abstract][Full Text] [Related]
22. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. Komai Y; Saito K; Sakai K; Morimoto S BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357 [TBL] [Abstract][Full Text] [Related]
23. [Clinical study of renal cell carcinoma as incidental finding]. Yazaki T; Iiyama T; Sato S; Hata R; Amemiya H; Tomomasa H; Muramatsu H; Iizumi T; Toyoshima A; Umeda T Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):409-15. PubMed ID: 1875560 [TBL] [Abstract][Full Text] [Related]
24. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma. Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542 [TBL] [Abstract][Full Text] [Related]
25. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker. Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952 [TBL] [Abstract][Full Text] [Related]
26. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545 [TBL] [Abstract][Full Text] [Related]
28. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma. Takashi M; Sakata T; Kato K Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529 [TBL] [Abstract][Full Text] [Related]
29. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection. Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597 [TBL] [Abstract][Full Text] [Related]
30. Real indications for adrenalectomy in renal cell carcinoma. Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919 [TBL] [Abstract][Full Text] [Related]
31. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. Erdem S; Yegen G; Telci D; Yildiz I; Tefik T; Issever H; Kilicaslan I; Sanli O World J Urol; 2015 Oct; 33(10):1553-60. PubMed ID: 25515319 [TBL] [Abstract][Full Text] [Related]
32. Elevated levels of serum aldolase A in patients with renal cell carcinoma. Takashi M; Zhu Y; Nakano Y; Miyake K; Kato K Urol Res; 1992; 20(4):307-11. PubMed ID: 1509638 [TBL] [Abstract][Full Text] [Related]
33. Serum iron as a tumor marker in renal cell carcinoma. Yu CC; Chen KK; Chen MT; Huang JK; Lin AT; Lee YH; Chang LS Eur Urol; 1991; 19(1):54-8. PubMed ID: 2007419 [TBL] [Abstract][Full Text] [Related]
35. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma. Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963 [TBL] [Abstract][Full Text] [Related]
36. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. Li G; Feng G; Gentil-Perret A; Genin C; Tostain J J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931 [TBL] [Abstract][Full Text] [Related]
38. Risk of metastasis for T1a renal cell carcinoma. Lee H; Lee JK; Kim K; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK World J Urol; 2016 Apr; 34(4):553-9. PubMed ID: 26245747 [TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma. Papworth K; Grankvist K; Ljungberg B; Rasmuson T Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777 [TBL] [Abstract][Full Text] [Related]